Myovant Sciences Ltd (MYOV)

[stockguard]

Regarding Sumitomo $MYOV Investor Rights Agreement-“will further include standstill provisions including a non-waivable condition requiring approval by a majority of the minority shareholders for any transaction that would cause Sumitomo...to hold beneficial ownership of Myovan of greater than 60%. Additionally for a standstill period of three years, any such transaction must also be made on a confidential basis to the independent directors and is subject to approval by a majority of the independent directors.” This explains why Sumitomo set up buying plan allowing them to get up to 60% ownership as cheaply as possible. The other 40% they realize will demand a fair deal to us minority shareholders.